Abiopharma

🔍 Szczepaniak Mark R (Executive)

Company: Velocity Financial, Inc. (VEL)

Report Date: 2026-06-26

Detailed Transactions and Holdings:

• Sold 1,573 shares of Common Stock at $18.0677 per share (Direct)
  Date: 2026-06-26 | Code: S | equity_swap_involved: false | shares_owned_after: 68,400.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-26 | Code: H | shares_owned_after: 101,535.00

Footnotes:

• F1: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.13. The reporting person undertakes to provide the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, the full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.